These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 25318209

  • 21. Correspondence (letter to the editor): National foundation.
    Freund M.
    Dtsch Arztebl Int; 2010 Sep; 107(38):671; author reply 673-4. PubMed ID: 20953259
    [No Abstract] [Full Text] [Related]

  • 22. [The drug industry and research: status in Germany].
    Geursen R.
    Zentralbl Chir; 1996 Sep; 121(7):603-5. PubMed ID: 8967203
    [Abstract] [Full Text] [Related]

  • 23. [Debate on clinical research without distortion of proportions].
    Verland K.
    Ugeskr Laeger; 2005 Apr 04; 167(14):1489. PubMed ID: 15887739
    [No Abstract] [Full Text] [Related]

  • 24. Medicine. Clinical trials and industry.
    Baird P, Downie J, Thompson J.
    Science; 2002 Sep 27; 297(5590):2211. PubMed ID: 12351773
    [No Abstract] [Full Text] [Related]

  • 25. Doctors and drug companies--scrutinizing influential relationships.
    Campbell EG.
    N Engl J Med; 2007 Nov 01; 357(18):1796-7. PubMed ID: 17978288
    [No Abstract] [Full Text] [Related]

  • 26. Report: FDA exerts too little oversight of researchers' conflicts of interest.
    Kuehn BM.
    JAMA; 2009 Feb 18; 301(7):709-10. PubMed ID: 19224741
    [No Abstract] [Full Text] [Related]

  • 27. Quantity counts: industrial-academic relationships and disclosures.
    Hall FM.
    Radiology; 2009 May 18; 251(2):612; author reply 612. PubMed ID: 19401585
    [No Abstract] [Full Text] [Related]

  • 28. Plan to force drug companies in France to reveal payments to doctors has been diluted, campaigners say.
    Benkimoun P.
    BMJ; 2012 Dec 12; 345():e8405. PubMed ID: 23236045
    [No Abstract] [Full Text] [Related]

  • 29. Disclosing clinical trial results: publicity, significance and independence.
    Liao SM, Sheehan M, Clarke S.
    Am J Bioeth; 2009 Aug 12; 9(8):W3-5. PubMed ID: 19998144
    [No Abstract] [Full Text] [Related]

  • 30. NerveCenter: Office of Inspector General warns NIH on lax COI oversight as many academic medical centers look inward.
    Samson K.
    Ann Neurol; 2010 Mar 12; 67(3):A7-A10. PubMed ID: 20373337
    [No Abstract] [Full Text] [Related]

  • 31. Predictable materiality: a need for common criteria governing the disclosure of clinical trial results by publicly-traded pharmaceutical companies.
    Cohen K, Cormier JW, Davar MV.
    J Contemp Health Law Policy; 2013 Mar 12; 29(2):201-32. PubMed ID: 23837261
    [No Abstract] [Full Text] [Related]

  • 32. [From the design of use study to the assessment of the benefit: with or without pharmaceutical industry?].
    Porzsolt F.
    Med Klin (Munich); 2010 Dec 12; 105(12):930-5. PubMed ID: 21240593
    [Abstract] [Full Text] [Related]

  • 33. Good pharma? Bad pharma? Better pharma.
    Hardman M.
    J R Coll Physicians Edinb; 2014 Dec 12; 44(4):269-72. PubMed ID: 25516893
    [No Abstract] [Full Text] [Related]

  • 34. [Physicians' participation in clinical drug trials].
    Nielsen OH, Ainsworth M.
    Ugeskr Laeger; 2003 Apr 14; 165(16):1639. PubMed ID: 12756815
    [No Abstract] [Full Text] [Related]

  • 35. Government regulators must steward drug transparency.
    Herder M.
    Nat Med; 2014 Aug 14; 20(8):806. PubMed ID: 25100518
    [Abstract] [Full Text] [Related]

  • 36. Transparency lacking. Despite Sunshine Act rules, policies still an issue.
    Lee J.
    Mod Healthc; 2013 Mar 11; 43(10):10-1. PubMed ID: 23593894
    [No Abstract] [Full Text] [Related]

  • 37. Physician payment disclosure under health care reform: will the sun shine?
    Mackey TK, Liang BA.
    J Am Board Fam Med; 2013 Mar 11; 26(3):327-31. PubMed ID: 23657702
    [Abstract] [Full Text] [Related]

  • 38. [Illegal professional conflict of interest from the viewpoint of the attorney].
    Broglie MG.
    Z Arztl Fortbild Qualitatssich; 1998 Oct 11; 92(8-9):627-31. PubMed ID: 9885174
    [Abstract] [Full Text] [Related]

  • 39. [Administrative organization and responsibility].
    Hilsted JC, Krogsgaard K.
    Ugeskr Laeger; 2003 Apr 14; 165(16):1641-2. PubMed ID: 12756816
    [Abstract] [Full Text] [Related]

  • 40. Marketing of antipsychotic drugs targeted doctors of Medicaid patients, report says.
    Roehr B.
    BMJ; 2012 Oct 02; 345():e6633. PubMed ID: 23033376
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.